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The import of cytochrome c into mitochondria can be resolved into a number of discrete steps. Here we report 
on the covalent attachment of heme to apocytochrome c by the enzyme cytochrome c heme lyase in mitochondria 
from Neurospora crassa. 
A new method was developed to measure directly the linkage of heme to apocytochrome c. This method is 
independent of conformational changes in the protein accompanying heme attachment. Tryptic peptides of 
[ 'Slcysteine-labelled apocytochrome c, and of enzymatically formed holocytochrome c, were resolved by reverse- 
phase HPLC. The cysteine-containing peptide to which heme was attached eluted later than the corresponding 
peptide from apocytochrome c and could be quantified by counting 35S radioactivity as a measure of 
holocytochrome c formation. Using this procedure, the covalent attachment of heme to apocytochrome c, which 
is dependent on the enzyme cytochrome c heme lyase, could be measured. Activity required heme (as hemin) and 
could be reversibly inhibited by the analogue deuterohemin. Holocytochrome c formation was stimulated 5 - 10- 
fold by NADH > NADPH > glutathione and was independent of a potential across the inner mitochondrial 
membrane. NADH was not required for the binding of apocytochrome c to mitochondria and was not involved 
in the reduction of the cysteine thiols prior to heme attachment. Holocytochrome c formation was also dependent 
on a cytosolic factor that was necessary for the heme attaching step of cytochrome c import. The factor was a 
heat-stable, protease-insensitive, low-molecular-mass component of unknown function. 
Cytochrome c heme lyase appeared to be a soluble protein located in the mitochondrial intermembrane space 
and was distinct from the previously identified apocytochrome c binding protein having a similar location. A 
model is presented in which the covalent attachment of heme by cytochrome c heme lyase also plays an essential 
role in the import pathway of cytochrome c. 
Cytochrome c is a component of the respiratory chain in 
the mitochondrial intermembrane space where it is reversibly 
associated with cytochrome c reductase and cytochrome c 
oxidase at the outer face of the inner membrane [l -41. It is 
imported into mitochondria by a pathway which is distinct 
from that of other nuclear-coded mitochondrial proteins (for 
review see [5 - 101). Apocytochrome c, the precursor of 
holocytochrome c, differs from its mature counterpart in that 
it does not contain covalently bound heme and has a different 
conformational arrangement. Apocytochrome c is a nuclear 
gene product which is translated on free cytoplasmic 
ribosomes (for review see [ll]) and is released, without a pre- 
piece [12-171, as a soluble protein into a cytoplasmic pool 
[18]. It is then post-translationally transferred into mito- 
chondria [12, 16, 18, 191 via specific receptors [20-221 and 
converted to holocytochrome c [12, 16, 18, 201 by covalent 
attachment of heme by the enzyme cytochrome c heme lyase 
[20, 23 - 261. Unlike most other imported mitochondrial pro- 
teins, but similar to those which must pass only the outer 
membrane [27 - 291, cytochrome c import and maturation is 
independent of a membrane potential [21]. 
The covalently attached heme of cytochrome c, which 
plays a crucial role in its function as an electron carrier, also 
appears to be important for events in the import pathway of 
cytochrome c. When heme attachment is inhibited by the 
analogue deuterohemin, the import of apocytochrome c is 
blocked at the stage of high-affinity receptor binding [20]. 
Apocytochrome c is tightly associated with mitochondria at 
this point but is in equilibrium with the soluble form since it 
can be displaced from its binding sites by incubation of the 
mitochondria with excess apocytochrome c. Upon reversal of 
deuterohemin inhibition with protohemin, the bound apo- 
cytochrome c is converted to holocytochrome c and the pro- 
tein is translocated completely across the outer mitochondrial 
membrane. This translocation appears to be intrinsically cou- 
pled to the covalent attachment of heme. A likely mechanism 
is that formation of the thioether linkages between the heme 
vinyl groups and the thiols of cysteines 18 and 21 of 
apocytochrome c (from Neurospora crassa, cysteines 14 and 
17 by universal numbering) initiates conformational changes 
along the polypeptide chain which result in driving the translo- 
cation of the protein across the outer membrane. This model 
is particularly attractive since there is no known energy re- 
Correspondence to W. Neupert, Institut fur Physiologische quirement, such as a membrane potential or ATP, for the Chemie, Physikalische Biochemie und Zellbiologie der Universitat 
Germany of the covalent attachment of the heme group to 
Abbreviations. Buffer A: 250 mM sucrose, 10 mM Mops/KOH apocytochrome C in the import pathway itself, the enzyme 
pH 7.2, 2 mM EDTA, 1 mM PMSF; hemin, Fe protoporphyrin Ix which catalyses this event, namely cytochrome c heme lyase 
C1; PMSF, phenylmethylsulfonyl fluoride; NEM, N-ethylmaleimide. (following recommendations of the IUPAC/IUB Commission 
Munchen, GoethestraBe 33, D-8000 Munchen 2, Federal Republic of import Of cytochrome c' Because Of the obvious importance 
148 
on Enzyme Nomenclature), plays a central role in the 
assembly of cytochrome c into mitochondria. 
We report here on the activity of cytochrome c heme 
lyase from the mitochondria of N .  crussa. The similarities and 
differences of the enzyme compared to that reported in yeast 
are discussed. A model is presented which pools our knowl- 
edge to date on the import and maturation of cytochrome c 
in mitochondria 
MATERIALS AND METHODS 
Cell growth 
Neurosporu ~'ru.ssu, wild-type 74A (Fungal Genetic Stock 
Center no. 262). was grown for 14 h at 25°C with vigorous 
aeration in Vogcl's minimal medium supplemented with 2% 
(w/v) sucrose liO]. The cultures were inoculated with lo9 
conidiail and grown under bright illumination. Where in- 
dicated, cells were radioactively labelled by growth under the 
same conditions except that sulfate was reduced to 0.08 mM 
and 3 mCi 3sSs04 (800- 1300 Ci/mmol, Amersham, Bucking- 
hamshire, England) were added per liter of culture. 
Isolation of rnirochondriu 
Unless otherwise indicated, all procedures were performed 
on ice or at 4 ('. Hyphae were harvested by filtration and 
immediately homogenized by grinding with quartz sand in 
Percoll medium [30% (v/v) Percoll (Pharmacia, Uppsala, 
Sweden), 180mM KC1, 304 (w/v) bovine serum albumin, 
1 mM EDTA. 1 mM PMSF, 10 mM Mops/KOH, pH 7.21 at 
a ratio of 3 ml Percoll medium and 1.5 g quartz sand per g 
(wet weight) of hyphae. Sand and cellular debris were removed 
by centrifugation for 5 min at 1900 x g (Beckman JA-20 
rotor), then again for 5 min at 3000 x g .  A gradient of Percoll 
was established in the resulting supernatant by centrifugation 
at 165000 x g  (Beckman Ti70 rotor) for 15 min. The mito- 
chondrial band was removed with a pasteur pipette and 
diluted with 20 vol. buffer A (250 mM sucrose, 10 mM Mops/ 
KOH, pH 7.2.2 mM EDTA, 1 mM PMSF addedimmediately 
before use from a 200 mM stock in ethanol). Mitochondria 
were sedimented by centrifugation for 12 min at 17400 x g 
(Beckman JA-20 rotor) and washed by resuspending them in 
the same volume of fresh buffer A. Mitochondria were again 
sedimented at 17400 x g  for 12 rnin and resuspended at a 
protein concentration of 5 mg/ml in buffer A or at 8 mg/ml 
for digitonin fractionation. 
Subfructionution c ? f '  mitochondria with digitonin 
Digitonin, recrystallized from ethanol, was prepared as a 
1% (w/v) stock solution in buffer A and was used within 
15 min. Dilutions were prepared with buffer A such that the 
concentrations were twofold the required final concentra- 
tions. Equal volumes (0.2 ml each) of the digitonin solution 
and mitochondria1 suspension (at 8 mg protein/ml) were 
combined for 60 s at 0 'C, then diluted with 0.5 ml buffer A. 
The mixture was layered on a 0.3-ml cushion of0.7 M sucrose, 
30 mM Tris/HCl, pH 7.5, and spun for 10 rnin at 48400 x g  
(Beckman JA-20 rotor with plastic adapters for 1.5-ml 
Eppendorf tubes). Both layers of the supernatant were 
carefully removed and the pellet was resuspended in 0.9 ml 
buffer A plus 0.3 ml of 0.7 M sucrose, 30 mM Tris/HCl 
pH 7.5 to mimic buffer conditions of the supernatants. The 
enzymatic activity of adenylate kinase [31] and fumarase [32] 
were determined as previously described. The fractionation 
of porin, cytochrome c, 20-kDa protein, ADP/ATP carrier 
and isocitrate dehydrogenase (N and f l  subunits) were deter- 
mined by resolving the samples on SDS/polyacrylamide gels 
[33] and Western blotting to nitrocellulose membranes [34, 
351. The membranes were incubated with a mixture of specific 
antibodies (against the above-mentioned proteins) and deco- 
rated with I4C-labelled protein A (prepared by reductive 
methylation in the presence of ['4C]formaldehyde as described 
previously for apocytochrome c [22]). The proteins were 
visualized by autoradiography and were quantified by cutting 
out the bands and determining radioactivity. 
The number of high-affinity binding sites for apocyto- 
chrome c was determined by Scatchard analysis essentially 
as previously described [22]. Mitochondria, or pellets from 
digitonin fractions, were suspended at a protein concentration 
of 1 mg/ml (starting material) in buffer A containing 50 pM 
deuterohemin, and were incubated for 5 min at 25°C. The 
samples were spun at 48 400 x g for 10 min (Beckman JA-20 
rotor) and the resulting pellets were resuspended at 0.3 mg 
protein/ml in 0.25 M sucrose, 50 mM NaCl, 2 mM EDTA, 
14 mM 2-mercaptoethanol, 1 % (w/v) bovine serum albumin, 
0.02% (w/v) holocytochrome c, 10 mM Mops/KOH, pH 7.2, 
in silicone-coated glass minivials. The samples were incubated 
with increasing amounts of ''C-labelled apocytochrome c, 
prepared by reductive methylation [22], for 20 min at 25 "C. 
Pellets were re-isolated by centrifugation as above, and the 
unbound apocytochrome c was measured in the supernatant 
by radioactivity determination. The pellets were lysed in 
0.5 ml of 1% (w/v) SDS, 100 mM TrisiHCl pH 8.0 and the 
bound apocytochrome c was also quantified by radioactivity 
determination. 
Cytosol fraction 
A post-ribosomal supernatant was prepared in the 
following manner. Hyphae were harvested by filtration and 
homogenized by grinding in quartz sand and buffer A at a 
ratio of 1 ml buffer A and 1.5 g quartz sand per g hyphae 
(wet weight). In preparations that were tested for protease 
sensitivity, PMSF was not included in buffer A but was added 
after protease treatment. A post-mitochondria1 supernatant 
was prepared to remove sand, cellular debris and most cellular 
organelles, by centrifugation at 27200 x g for 15 min (Beck- 
man JA-20 rotor). The resulting supernatant was then spun 
for 60 min at 226000 x g  (Beckman Ti 50 rotor). The upper 
two-thirds of the supernatant of this preparation was carefully 
removed and taken as the cytosol fraction. 
Measurement of cytochrome c heme lyase activity 
Principle of the method. Apocytochrome c from N .  crassa 
contains two cysteines at positions 18 and 21 (positions 14 
and 17 according to standardized nomenclature) which form 
thioether bridges with the vinyl groups at positions 3 and 8 
(IUPAC numbering) of protoheme, respectively, to produce 
holocytochrome c. Although it is difficult to resolve apo- and 
holocytochrome c by conventional techniques, their respective 
tryptic peptide patterns can be clearly distinguished by re- 
verse-phase HPLC. The only peptide which is affected is the 
cysteine-containing peptide which has a far greater retention 
time when heme is covalently attached to it. By incorporating 
[35S]cysteine into apocytochrome c, the rate of formation of 
a radiolabelled peptide with a longer retention time (owing to 
the heme group) can be used as a measure of cytochrome c 
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heme lyase activity. To do this, samples were incubated with 
the post-ribosomal supernatant of reticulocyte lysates which 
had been programmed by N .  crassa poly(A)-containing RNA 
and were translated in the presence of [35S]cysteine. Cyto- 
chrome c was purified from these incubations by immunopre- 
cipitation and digested with trypsin. The resulting peptide 
mixture was resolved by reverse-phase HPLC and the heme/ 
cysteine-containing peptide was collected and its radioactivity 
measured. 
Incubation mixtures. Samples, containing up to 100 pg 
protein, were pre-incubated for 5 rnin at 25 "C in the presence 
of 6.7 mM NADH plus any additions, in a total volume of 
150 pl buffer A. The reaction was started by adding 50 p1 of 
post-ribosomal supernatant of reticulocyte lysate that had 
been translated in the presence of [35S]cysteine (therefore 
200 pl final incubation volume, 5 mM NADH). Following a 
further incubation for 10 rnin at 25"C, the reaction was halted 
by cooling the samples to 0°C. In experiments using whole 
mitochondria, the samples were diluted with 1 ml buffer A and 
mitochondria were re-isolated by centrifugation for 12 min at 
17400 x g. The pellets were prepared for immunoprecipitation 
by resuspending them in 1 ml of 1% (w/v) Triton X-100, 
0.3 M NaCl, 10 mM Tris/HCl pH 7.2. Other samples were 
directly dissociated in 1 ml of this buffer. 
Immunoprecipitation of cytochrome c. Samples were 
shaken for 15 min at 4°C and were then clarified by centrifu- 
gation for 15 rnin at 27200 x g (Beckman JA-20 rotor). During 
this time, immunoglobulins from antisera raised against 
Neurospora holocytochrome c were pre-bound to protein-A - 
Sepharose by mixing for 15 rnin at 4°C. Depending on the 
titre, usually 50 p1 serum was mixed with 7.5 mg protein-A- 
Sepharose (Bioprocessing, London, England). The super- 
natants from the clarified samples were mixed with the 
antibody/protein-A - Sepharose complexes and shaken for 
60 rnin at 4°C. Sepharose beads were collected by centrifuga- 
tion at 8900 x g for l rnin in an Eppendorf centrifuge. The 
pellets were washed (by shaking for 1 min followed by cen- 
trifugation at 8900 x g)  twice with 1 ml of 1 % (w/v) Triton 
X-100, 0.3 M NaCl, 10 mM Tris/HCl pH 7.2, once with 1 ml 
of 1 mM K,[Fe(CN)6] in 10 mM Tris/HCl pH 7.0 (to oxidize 
cytochrome c for uniform tryptic digestion [36]), and twice 
more with 1 ml 10 mM Tris/HCl pH 7.0. The cytochrome c 
was eluted from the immunocomplexes by shaking the beads 
for 15 rnin in 60 p1 of 8 M urea at room temperature followed 
by 30 min at 56°C and additional shaking for 15 min at room 
temperature. The protein-A - Sepharose was sedimented by 
centrifugation at 8900 x g for 3 min and the supernatant 
was retained. The efficiency of elution by this method was 
Digestion with trypsin. The eluted immunoprecipitates 
(55 pl) were incubated in a total volume of 300 pl containing 
60 mM NH4HC03, 25 pg of purified Neurospora holocyto- 
chrome c (for a marker) and 50 pg trypsin (type XI11 from 
bovine pancreas, treated with tosylphenylalanylchlorome- 
thane, 10000 U/mg, Sigma, St. Louis MO) for 90 rnin at 37°C. 
Under these conditions, the diluted urea (approximately 
1.5 M) did not affect trypsin activity. Following incubation, 
the samples were cooled to room temperature and made 0.1 % 
(v/v) in trifluoroacetic acid (Sigma) by adding 6 pl of a 5% 
(v/v) stock. 
HPLC analysis. The tryptic peptide mixtures were resolved 
by reverse-phase HPLC on a Waters Associates (Milford, 
MA) pBondapak phenyl column (3.9 mm x 30 cm, 10 pm 
particle size, see [37]). For analytical runs, the column was 
equilibrated at a flow rate of 0.8 ml/min in solvent A (O.l%, 
60 - 70%. 
v/v, CF3C02H). Following sample injection, the peptides 
were eluted with a linear gradient of 0 - 50% solvent B (0.1 YO 
CF3C02H, 9.9% HzO, 90% CH3CN; v/v/v) as described in 
Fig. 1. 
Using this protocol, the cysteine-containing tryptic 
peptide from apocytochrome c eluted at 37.5 rnin following 
injection while the cysteine-containing peptide from holocyto- 
chrome c eluted at 58.2 min. The total run time, including 
column re-equilibration, was 90 min. During routine analysis, 
an abbreviated program was used in which the column was 
equilibrated in 80% solvent A/20y0 solvent B and eluted 
by a linear gradient of 20-50% solvent B. Following this 
protocol, the apo-cysteine peptide eluted shortly following the 
column void volume whereas the holo-cysteine peptide was 
retained for 29.0 min. Total run time, including re-equilibra- 
tion, was 45 min. All HPLC runs were performed at a constant 
flow rate of 0.8 ml/min at room temperature. For determina- 
tion of cytochrome c heme lyase activity, the holocytochrome 
c cysteine-containing tryptic peptide was collected (by 
monitoring the marker holocytochrome c peptides at 415 nm) 
and its radioactivity measured. 
Miscellaneous methods 
Apo- and holocytochrome c were purified from N .  crassa 
and specific antibodies were raised in rabbits as previously 
described [30]. Preparation of rabbit reticulocyte lysates and 
cell-free protein synthesis directed by N. crassa poly(A)-con- 
taining RNA [38] was performed essentially as described 
before [39] except: (a) ~-[~~S]cysteine (sp cific activity 1100 - 
1400 Ci/mmol, Amersham) was used in an amino acid mixture 
which lacked unlabelled cysteine; (b) following translation, a 
post-ribosomal supernatant was prepared by centrifugation 
for 60 rnin at 226000 x g (Beckman Ti 50 rotor) which was 
then made iso-osmotic (for mitochondria) by adding sucrose 
to a final concentration of 0.25 M; (c) during translation, the 
mixture contained either 13 pM hemin (10 pM in the sucrose- 
diluted post-ribosomal preparation) or 5 mM CAMP [40]. 
Radioactivity determinations were performed by scintilla- 
tion counting in either 1 ml of 1% (w/v) SDS, 100 mM Tris/ 
HC1, pH 8.0 plus 10 ml ACS I1 (Amersham) for samples from 
the HPLC, or in 0.5 ml of 1% (w/v) SDS, 100 mM Tris/HCl 
pH 8, plus 12 ml of a cocktail containing 60% (v/v) toluene, 
40% (v/v) methylglycol, 6 g/1 Permablend I11 (Packard, 
Zurich, Switzerland) for all other samples. Protein was deter- 
mined by the method of Bradford [41]. SDS/polyacrylamide 
gel electrophoresis was performed using standard techniques 
[33]. Immunoprecipitates were dissociated by incubation at 
95°C for 5 min in SDS-sample buffer [2% (w/v) SDS, 0.35 M 
2-mercaptoethanol, 50 mM Tris/HCl pH 6.8, 10% (v/v) glyc- 
erol, 0.005% (w/v) bromophenol blue]. Gels were prepared 
for fluorography by soaking them for 30min in Amplify 
(Amersham) prior to drying. Bands in the original gel were 
quantified by scanning for radioactivity on a thin-layer 
chromatograph linear analyzer (Berthold, Wildbad, FRG). 
RESULTS 
Measurement of cytochrome c heme lyase activity 
A method for directly measuring the covalent attachment 
of heme to apocytochrome c was developed which was inde- 
pendent of related changes in the protein molecule (i.e. 
conformational). Apo- and holocytochrome c could be 
separated by reverse-phase HPLC regardless of conformation 
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Fig. 1 .  Kcsolutiorr of rryptic peptides of cytochrome c by reverse-phase HPLC. Samples were applied to a Waters pHondapak phcnyl column 
equilibrated in 0.1"h (viv) CF3C02H and eluted with a linear gradient of solvent B (0.1% CF3C02H, 9.9% HZO, 90% CH3CN, v h k )  as 
indicated in A. C'hromatographs were monitored at 215 nm and 415 nm (A-C) or fractions were collected at 0.5-min intervals (D) and 
counted for radioactivity. (A) Mixture containing 100 pg each of apocytochrome c and holocytochrome c. (B) Holocytochrome c tryptic 
peptides: 200 pg holocytochromc c were digested in a total volume of 50 p1 60 mM NH4HC03 with 10 pg trypsin for 15 h at 37°C. (C) 
Apocytochrome 1' tryptic peptides: as B except with 200 pg apocytochrome c. (D) Identification of cysteine-containing peptides (fractions not 
presented contained no detectable radioactivity): (+) apocytochrome c was immunoprecipitated from 25 pl of [35S]cystcine-labelled reticulocytc 
lysate, immunoprccipitates were eluted with urea and digested with trypsin; ( 0 )  holocytochrome c was immunoprecipitated from 100 pg 
mitochondria1 protein from cells that were grown in the presence of 35S04, immunoprecipitates were eluted then digested with trypsin. The 
amino acid sequence of A'. crassa cytochrome c is presented above A (see [42,43]) 
(i.e. under native or denaturing conditions) but not with ad- 
equate resolution for use in routine analysis (Fig. 1A). 
Although the effect of the heme group on the retention time 
of the whole cytochrome c molecule was only slight, the effect 
on a smaller peptide fragment was expected to be considerably 
greater. The peptides generated by the digestion of cyto- 
chrome c with trypsin results in a mixture containing one 
peptide (amino acids 18-31) in which the heme attachment 
sites (cysteines 18 and 21) are located. This fragment has the 
advantageous feature of containing the only two cysteines in 
the Neurospora c Y L ~ S S ~  cytochrome c molecule. Using [35S]cy- 
steine-labelled cytochrome c, the migration of the cysteine- 
containing peptide could be specifically determined as a means 
for measuring holocytochrome c formation. 
Two approaches were used to identify the cysteine-con- 
taining tryptic peptide from apo- and holocytochrome c. First, 
the purified proteins were digested with trypsin and the re- 
sulting peptides were resolved by reverse-phase HPLC. In the 
case for both apo- and holocytochrome c, 18 fragments could 
be distinguished (theoretically, there are 17 tryptic cleavages 
sites in Neurosporu cytochrome c). Holocytochrome c 
(Fig. 1 B) contained a single peptide absorbing at 415 nm 
(owing to the heme group) which had a retention time of 
58.2 min (peptide 17). This peptide was not present in the 
tryptic digests of apocytochrome c. Likewise, apocytochrome 
c (Fig. 1C) contained a unique peptide (no. 5 )  which had a 
retention time of 37.5 min and was not present in tryptic 
digests of holocytochrome c. To confirm that peptide 5 was 
the cysteine-containing peptide of apocytochrome c and that 
peptide 17 was the corresponding peptide from holocyto- 
chrome c but with covalently attached heme, a second 
approach was used (Fig. 1 D). Apocytochrome c was immuno- 
precipitated from the post-ribosomal supernatant of re- 
ticulocyte lysates [programmed by N.  crussa poly(A)-contain- 
ing RNA] which had been translated in the presence of 
[35S]cysteine. The immunoprecipitates were eluted and 
digested with trypsin, then the resulting peptides were resolved 
by reverse-phase HPLC. A single radioactive peak cor- 
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responding to the position of peptide 5 was observed. 
Holocytochrome c was immunoprecipitated from isolated 
mitochondria prepared from Neurospora cultures that were 
metabolically labelled by growth in the presence of 35S04, 
and processed in the same way. In this case, a major radio- 
active peak corresponding to peptide 17 was observed. In 
addition, two smaller peaks containing [3 'Slmethionine were 
also resolved (peptide 11 containing methionine 102, and 
peptide 13 containing methionine 84). This confirmed that the 
cysteine-containing tryptic peptide of cytochrome c cor- 
responded to peptide 5 without covalently attached heme (i.e. 
from apocytochrome c) and to peptide 17 with covalently 
attached heme (i.e. from holocytochrome c)  and formed the 
basis of an HPLC-based assay system for the measurement of 
holocytochrome c formation by the activity of cytochrome c 
heme lyase. 
Following the incubation of [35S]cysteine-containing re- 
ticulocyte lysates with Neurospora mitochondria, appearance 
of radioactivity co-migrating with peptide 17 occurred with a 
concomitant decrease in the radioactivity in peak 5. Under 
optimal conditions, up to 30% of the cysteine radioactivity in 
peak 5 (from apocytochrome c) could be converted to peak 
17 (holocytochrome c). The assay was linear for 12min at 
25"C (the optimal temperature) and up to 100 pg mitochon- 
drial protein. Activity was optimal at pH 7.0 and exhibited a 
broad pH range with 50% activity remaining at pH 5.5 or 
pH 8.5 (data not presented). The error between replicate 
samples was less that 5%. Using this system, the activity of 
cytochrome c heme lyase could be measured directly and did 
not rely on secondary changes such as those required for 
distinguishing between apo- and holocytochrome c with 
specific antibodies or by differential protease sensitivity. 
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Cytochrome c heme lyase is dependent on heme 
and can be reversibly inhibited by the analogue deuterohemin 
The preparation of reticulocyte lysates normally used in 
the measurement of cytochrome c heme lyase activity contains 
hemin, which is added to inhibit the phosphorylation of initia- 
tion factor 2 during translation. To examine the requirement 
for heme (as hemin) by cytochrome c heme lyase, CAMP was 
substituted to perform this function [40]. Cytochrome c heme 
lyase activity could then be measured using hemin-free re- 
ticulocyte lysates. Holocytochrome c formation was depen- 
dent on exogeneously added hemin (Fig. 2A) and was optimal 
at 2 pM hemin (equivalent to approximately 5 nmol hemin/ 
mg mitochondrial protein). Activity was progressively in- 
hibited at higher concentrations, explaining the observation 
that hemin added to incubation mixtures using normal hemin- 
containing reticulocyte lysates inhibits activity. When the 
heme analogue deuterohemin (which does not contain the 
vinyl groups at positions 3 and 8 of the porphyrin ring) was 
added to incubation mixtures using hemin-containing re- 
ticulocyte lysates (2.5 pM final concentration of hemin contri- 
buted by the reticulocyte lysate), cytochrome c heme lyase 
activity was inhibited (Fig. 2B). Deuterohemin only mar- 
ginally affected the binding of apocytochrome c to mitochon- 
dria (i.e. 13.4% reduced at 50 pM deuterohemin, data not 
presented). Activity was inhibited by 50% at approximately 
2.5 pM deuterohemin (the same concentration as hemin from 
the reticulocyte lysate) suggesting that the enzyme has equiva- 
lent affinity for deuterohemin and for hemin. Activity was 
reduced by 93% at 25 pM deuterohemin and nearly 
completely abolished at 50 pM. This inhibition by 
deuterohemin could be reversed with hemin, but only under 
c 2 4 6 0 1 0  
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Fig. 2. Dependence of cytochrome c heme base on hemin, and reversible 
inhibition of activity by deuterohemin. (A) Activity was determined (as 
described in Methods) in samples containing 75 pg mitochondrial 
protein using [35S]cysteine-labelled reticulocyte lysates that had been 
translated in the presence of CAMP instead of hemin. Hemin was 
added as indicated. (B) Activity was measured in mitochondria (75 vg 
protein) using normal reticulocyte lysates (containing hemin) with 
increasing concentrations of deuterohemin. The final concentration 
of hemin in the assay mixture (contributed by the reticulocyte lysate) 
was 2.5 pM. (C) Mitochondria (75 pg) were pre-incubated with either 
25 pM (0) or 50 pM (0) deuterohemin (DH) for 5 rnin at 25 "C in a 
mixture containing 6.7 mM NADH in a total volume of 150 p1 buffer 
A. After adding 50 p1 [35S]cysteine-labelled reticulocyte lysate, the 
samples were incubated for 10 rnin more at 2 5 T ,  then mitochondria 
were re-isolated by diluting the samples in 1 ml buffer A and 
sedimenting them for 12 rnin at 17400 x g. The mitochondria were 
suspended in 200 pl buffer A containing 5 mM NADH, 50 pl 
unlabelled reticulocyte lysate and varying concentrations of hemin. 
Following further incubation for 10 rnin at 2 5 T ,  holocytochrome c 
formation was determined. In a parallel experiment, samples were 
incubated with 25 pM deuterohemin as above but mitochondria were 
not re-isolated before hemin addition (A).  Hemin was added at the 
concentrations indicated and the samples were incubated 10 rnin more 
at 25°C. Holocytochrome c formation was then determined. Control 
mitochondria were not treated with deuterohemin or hemin but other- 
wise were processed the same (- - - -) 
limited conditions (Fig. 2C). In samples that were inhibited 
with 25 pM deuterohemin, 78% of the activity was recovered 
with 100 pM hemin; however, inhibition could not be reversed 
when activity was inhibited with 50 pM deuterohemin. Fur- 
thermore, mitochondria had to be re-isolated following in- 
cubation with deuterohemin otherwise only a small propor- 
tion of the original activity could be regained. In summary, 
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5 mM (i.e. 17.5% reduction of apocytochrome c binding at 
25 mM NADH, data not presented). 
c 1-, I 
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Glutathione ( r n M )  
Fig. 3 .  Ej7ec.1 of'rrducing ugmts on cytochrome c heme lyase activity. 
Mitochondria (75 pg protein) were incubated in a standard mixture 
containing various concentrations of: (0) NADH; (0 )  NAD'; (El) 
NADPH; (+) ascorbate plus 0.25 mM tetramethylphenylenediamine 
(AscJTMPD); ( I. ) ylutathione (GSII, reduced form) 
under defined conditions the enzymatic activity of cytochrome 
c heme lyase, which was dependent on hemin, could be com- 
petitively and reversibly inhibited by the analogue deutero- 
hemin. 
Holocytochromt~ c formution is dependent on NADH 
Mitochondria incubated with reticulocyte lysates in the 
absence of reducing agents converted very little apocyto- 
chrome c to holocytochrome c. In the presence of NADH, 
however, holocytochrome c formation was stimulated up to 
10-fold (Fig. 3 A). The optimal concentration varied between 
mitochondrial preparations but ranged between 1 mM and 
10 mM NADH. Stimulation of activity was also observed 
with NADPH or NAD', up to 45% of the maximum activity 
observed with NAIIH. When NAD' was added to incubation 
mixtures in the presence of an NADH-regenerating system 
(either lactate dehydrogenase plus L-lactate, or glucose-6- 
phosphate dehytirogenase plus D-glucose 6-phosphate), the 
stimulation of holocytochrome c formation by NAD' was 
nearly identical t o  the stimulation by NADH alone. No in- 
crease in activity was observed when a mem- 
brane potential was generated by N,N,N',N'-tetramethyl-p- 
pheuylenediamine plus ascorbate (Asc./TMPD). Similarly, 
the stimulation of activity by NADH was unchanged when 
the membrane potential was either dissipated by valinomycin 
(0.5 pM) plus K I ,  or when its generation was blocked by 
the combination of antimycin A plus oligomycin (8 pM and 
20 pM, respectively). Reduced glutathione also enhanced 
holocytochrome c formation but was required at significantly 
higher concentrations than observed for NADH (Fig. 3B). 
Preliminary experiments indicate that glutathione stimulates 
activity by reversing the reaction catalyzed by glutathione 
reductase to form NADH. NADH was not required for the 
binding of apocytochrome c to mitochondria and, in fact, it 
progressively reduced binding at concentrations greater than 
Covalent attachment of heme to apocytochrome c is blocked 
by N-ethylmaleimide 
When mitochondria were pre-treated with varying concen- 
trations of N-ethylmaleimide (NEM) then reisolated (so NEM 
would not react with apocytochrome c when added), 
holocytochrome c formation was unaffected (Fig. 4B). This 
indicated that none of the import machinery for cytochrome 
c has essential free sulphydryl groups. NEM pretreatment of 
apocytochrome c in reticulocyte lysates, however, resulted in 
nearly complete loss of conversion to holocytochrome c by 
mitochondria. This inhibitory affect was not due to reduction 
of the ability of NEM-treated apocytochrome c to bind to 
mitochondria (Fig. 4A) since NEM did not significantly affect 
binding (except at 20 mM where a 25% reduction in 
mitochondria-associated apocytochrome c was observed). 
When apocytochrome c was pre-bound to mitochondria and 
then treated with NEM, conversion to holocytochrome was 
inhibited. The concentrations of NEM required for inhibition 
were similar to those required for inhibition of holocyto- 
chrome c formation from NEM-treated apocytochrome c in 
the reticulocyte lysate using untreated mitochondria, except 
for a slight latency which may reflect a reduced accessibility 
of NEM to the pre-bound apocytochrome c. Since the pre- 
bound apocytochrome c was able to react with NEM (which 
blocks only free SH groups) in the absence of NADH, then 
the apocytochrome c cysteines are reduced throughout the 
import pathway and this suggests that NADH is not involved 
in their reduction. 
A factor found in reticulocyte lysate or cell cytosol 
is necessary for holocytochrome c formution 
When mitochondria were incubated with reticulocyte 
lysate in varying total volumes, the conversion of apo- to 
holocytochrome c was considerably reduced in dilute samples 
while the binding of apocytochrome c to mitochondria was 
only marginally affected (Fig. 5A). This effect was observed 
regardless of whether the absolute concentration of hemin was 
kept constant (Fig. 5A) or the ratio ofhemin to mitochondrial 
protein was held constant (not shown). This implied that a 
factor, other than hemin, which was present in the reticulocyte 
lysate was necessary for holocytochrome c formation. To 
examine whether a similar factor was present in Neurospora 
cytosol, apocytochrome c was pre-bound to mitochondria in 
the absence of NADH, the mitochondria were re-isolated and 
washed, and the dependence of holocytochrome c formation 
on a cytosolic fraction was determined. In the presence 
of all other known requirements for cytochrome r heme 
lyase activity (apocytochrome c pre-bound to mitochondria, 
NADH and hemin), conversion of apocytochrome c to 
holocytochrome c was low in the absence of cytosol but was 
stimulated five-fold when the cytosolic preparation was in- 
cluded (Fig. 5B). When holocytochrome c formation was 
assayed this way in the presence of non-radioactive re- 
ticulocyte lysate instead of cytosol, a similar effect was also 
observed. The cytosolic fraction alone, in the absence of 
mitochondria, did not catalyse holocytochrome c formation. 
Stimulation by cytosol was also dependent on NADH (i.e. no 
increase in activity was observed in the absence of NADH) 
and the effect of the cytosolic fraction on activity could not 
be substituted for by an NADH-regenerating system. When 
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Fig. 4. Effect of N-ethylmaleimide on the conversion of apocytochrome 
c to holocytochrome c. (A) Effect of N-ethylmaleimide (NEM) on 
binding of apocytochrome c to mitochondria. [35S]Cysteine-labelled 
reticulocyte lysates (50 pl) were treated with varying concentrations 
of NEM for 60 rnin at 0°C in a total volume of 100 p1 buffer A. 
Mitochondria (75 pg protein) were incubated with 50 pM 
deuterohemin for 5 rnin at 25°C in a total volume of 100 pl, then 
combined with 100 pl of the reticulocyte lysate/NEM mixture and 
incubated for an additional 10 min at 25°C. The samples were diluted 
in 1 ml buffer A and mitochondria were re-isolated by centrifugation 
for 12 min at 17400 x g. Cytochrome c was immunoprecipitated with 
a mixture of apo- and holocytochrome c antisera. The precipitates 
were dissociated in SDS-sample buffer and resolved on SDS/poly- 
acrylamide gels. The gels were dried and visualized by fluorography. 
(B) Effect of NEM on holocytochrome c formation. Either 75 pg of 
mitochondrial protein ( A )  or 50 pl [35S]cysteine-labelled reticulocyte 
lysate (0) were treated with NEM for 60 rnin at 0°C in a total volume 
of 100 pl buffer A at the indicated concentrations. In the case of 
treatment of mitochondria with NEM, they were then re-isolated as 
above. Heme attachment was measured by adding 50 p1 of untreated 
[35S]cysteine-labelled reticulocyte lysate. In the case of treatment of 
the reticulocyte lysate with NEM, 75 pg mitochondrial protein was 
added. The total volumes in both cases were 200 p1 in buffer A 
containing 5 mM NADH. The mixtures were incubated for 10 rnin at 
25 "C, mitochondria were re-isolated and holocytochrome c formation 
was determined. In a third experiment (U), apocytochrome c from 
[3 5S]cysteine-labelled reticulocyte lysate was pre-bound to mitochon- 
dria in the absence of NADH by incubating 75 pg mitochondrial 
protein with 50 pl of the lysate in a total volume of 200 pl buffer A 
for 10 min at 25°C. Mitochondria were re-isolated as above and 
suspended in 100 pl buffer A containing varying concentrations of 
NEM. The samples were incubated for 60 rnin at O"C, then mitochon- 
dria were re-isolated. The mitochondria were incubated in a total 
volume of 200 pl buffer A containing 35 pl cytosol fraction, 5 mM 
NADH and 2 pM hemin for 10 rnin at 25°C. Holocytochrome c 
formation was then determined. ( A )  Treatment of mitochondria with 
NEM; (0) treatment of reticulocyte lysate with NEM; (El) treatment 
of mitochondria containing bound apocytochrome c with NEM 
cytosol was added to standard incubation mixtures containing 
mitochondria, [35S]cysteine-labelled reticulocyte lysate and 
NADH, activity was stimulated two-fold, suggesting that the 
stimulation of activity by the factor from reticulocyte lysate 
and cytosol were additive or that the content of the factor in 
the reticulocyte lysate was below the concentration necessary 
for optimal activity. 
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Fig. 5. Dependence of cytochrome c heme lyase activity on a factor 
,from reticulocyte lysate and cytosol. (A) Dilution of reticulocyte lysate. 
In parallel samples, 75 pg mitochondrial protein was pre-incubated 
in varying volumes of buffer A (as indicated, minus 50 pl), 5 mM 
NADH and 5 pM hemin (final concentration after addition of re- 
ticulocyte lysate) for 5 rnin at 2 5 T ,  then for an additional 10 rnin at 
25 "C after adding 50 p1 [35S]cysteine-labelled reticulocyte lysate. The 
samples were cooled to 0°C and diluted to a total volume of 1 ml 
with buffer A. Mitochondria were re-isolated by sedimenting them for 
12 min at 17400 x g .  Total cytochrome c associated with mitochondria 
( 0 )  was measured by immunoprecipitating samples with a combina- 
tion of antisera directed against apo- and holocytochrome c. Bands 
were quantified by scanning gels for radioactivity. Holocytochrome 
c formation was measured in the parallel samples (0). Values are 
expressed as percentage of the undiluted control (0.1 ml). (B) Titration 
of stimulation by cytosol. Apocytochrome c from [35S]cysteine- 
labelled reticulocyte lysate was pre-bound to mitochondria in the 
absence of NADH (therefore no conversion to holocytochrome c)  by 
incubating a mixture containing 750 pg mitochondrial protein and 
500 pl [3 5S]cysteine-labelled reticulocyte lysate in a total volume of 
2 ml buffer A for 10 rnin at 25°C. Mitochondria were re-isolated by 
centrifugation for 12 rnin at  17400 x g and resuspended in buffer A. 
Cytosolic stimulation of activity was determined by incubating a 
mixture containing 75 pg mitochondrial protein containing pre- 
bound apocytochrome c, 5 mM NADH, 5 pM hemin and varying 
concentrations of cytosol fraction in a total volume of 200 p1 buffer A 
for 10 rnin at 25 "C. Holocytochrome c formation was then determined 
(0) 
To examine the nature and possible role of this factor in 
holocytochrome c formation, cytosolic preparations were pre- 
treated under various conditions and then their ability to 
stimulate holocytochrome c formation from apocytochrome 
c, pre-bound to mitochondria, was determined (Table 1). The 
stimulating factor was a heat-stable, low-molecular-mass 
cytosolic component that was not sensitive to trypsin. When 
it was dialyzed out of cytosolic preparations, the resulting 
dialyzate could be concentrated and the stimulating activity 
recovered. To substantiate further that the factor was not 
hemin, dialyzed cytosol (which did not significantly affect 
activity) was supplemented with hemin and used to stimulate 
holocytochrome c formation. The dialyzed cytosol treated 
this way did not affect activity any more than the dialyzed 
cytosol alone. Equivalent volumes of unlabelled reticulocyte 
lysate (35 pl per 200 pl total volume) stimulated activity to 
63% of that observed with untreated cytosol. Using 50 pl of 
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Table 1. Sti tn~iki tr~i i~ oj'cytochrome c heme lyase activity by cytosolic 
fruc t ions 
Apocytochrome c '  from [35S]cysteinc-labclled reticulocyte lysate was 
pre-bound to mitochondria in the absence of NADH as described in 
Fig. 5 B. The mitochondria were reisolated and suspended in amixture 
containing 75 pg mitochondrial protein, 5 mM NADH, 2 pM hemin 
and 35 pl ofa cytowlic fraction or reticulocyte lysate in a total volume 
of 200 pl buffer A The samples were incubated for 10 min at  25°C 
and holocytochrotne l' formation was determined. In experiment I, 
cy~osol fracfjon, were pretreated in the following manner: (2) no 
treatment; ( 3 )  healing for 5 min at  95°C; (4) five cycles of slow 
freezing to - 2 0  C ' ,  thcn thawing to 25 'C ;  (5) extensive dialyzing 
against buffer A overnight at 4 C in Visking 8/32 tubing (Union 
Carbide, Chicago 11.): (6) 40 pg trypsin was preincubated with 800 pg 
soybean trypsin inhibitor for 5 min at  25°C; the mixture was then 
added to 1 mi cytosol and further incubated for 20 min at  25°C; (7) 
incubation for  20 min at 25 'C with 4 pg trypsin/ml cytosol then for 
5 min at  25 (. with 80 pg soybean trypsin inhibitor/ml; (8) as in (7) 
except with 40 pg trypsiniml cytosol and 800 pg soybean trypsin 
inhibitor/ml; (9 and 10) no cytosol, but with 35 p1 and 50 pl (respec- 
tively) of thc post-ribosomal supernatant of reticulocyte lysate con- 
taining unlabellcd cysteine instead of [35S]cysteine. In experiment 11, 
fractions (12) and (23) werc treated as (2) and (5), respectively; (14) 
the dialyzatc from (13) was saved, lyophilizcd, and suspended in 
H 2 0  in the samc volume as the original sample; (15) the incubation 
mixtures containing the dialyzed cytosol(l3) were supplemented with 
2 pM hemin. Thc activity of the sample with untreated cytosol (2) 
and (1 1)  were set at 200% 
Expt Condition Activity 
I (1) no cqtosol 
(2) control 
(3) 5 min 9q C 
(4) freere th,lLv 
(6) mock irypsin 
(7) 4 pg Irypsm/ml 
(8) 40 pg trypsin/ml 
(9) 35 pl reticulocyte lysate 
(20) 50 p1 reticulocyte lysate 
(12) control 
(13) didly/ed ~jtosol 
(14) dialy/,itc 
(15) didl)xd cytosol + hemin 
( 5 )  dirtly\l\ 
I1  ( 2 1 )  no cqto\o1 
fmolxmin- ' xmg-  
(YO) 
0.0266 (10.8) 
0.246 (100) 
0.268 (109) 
0.249 (101) 
0.0413 (16.8) 
0.208 (84.6) 
0.216 (87.8) 
0.201 (81.7) 
0.155 (63.0) 
0.209 (85.0) 
0.0313 (16.6) 
0.188 (100) 
0.0402 (21.4) 
0.159 (84.6) 
0.0353 (18.8) 
I 
unlabelled reticulocyte lysate (equal to the amount of lysate 
normally used per incubation mixture) holocytochrome c 
formation occurred at 85% of the optimal rate observed with 
cytosol. The exact identity and role of this factor is unclear 
from these experiments, except that it is not required for the 
binding of apocytochrome c to mitochondria. It is therefore 
most likely required for the activity of cytochrome c heme 
lyase. 
Cytochrome c hiwe lyuse is located 
in the initochondrial intermembrane spuce and is distinct 
from the a/,oc:)~toc.hrome c binding protein 
Mitochondria were subfractionated by digitonin treat- 
ment in order to answer two questions, namely: (a) where is 
cytochrome (' heme lyase localized and (b) is cytochrome c 
heme lyase distinct from the previously identified apocyto- 
chrome c' binding protein (Kohler, Stuart and Neupert, 
unpublished results)? To address the second question, 
advantage was taken of the particular fractionation 
behaviour. The apocytochrome c binding protein cofrac- 
tionates with intermembrane space markers in swelling and 
sonication experiments but exhibits some latency in release 
in the presence of increasing concentrations of digitonin. If 
cytochrome c heme lyase and the apocytochrome c binding 
protein were the same protein, then this delay in the release 
of cytochrome c heme lyase activity would be expected as well. 
Mitochondria were carefully isolated by Percoll-gradient 
centrifugation and fractionated by digitonin (Fig. 6). High- 
affinity binding sites for apocytochrome c correlated with 
the amount of binding protein and fractionated as a hybrid 
between the outer membrane (porin) and intermembrane 
space (presumably associated with the inner face of the outer 
membrane). Cytochrome c heme lyasc activity could not be 
detected in any of the supernatant fractions, but loss of activi- 
ty from the pellets correlated with the loss of intermembrane 
space markers. The possibility that the loss of activity was 
due to inhibition of activity by digitonin was excluded by 
other experiments, such as fractionation by sonication and 
fractionation by swelling in hypotonic buffers. In all cases, 
loss of cytochrome c heme lyase activity correlated with the 
release of intermembrane space markers (unpublished experi- 
ments). The ability of the digitonin-treated mitochondria to 
bind apocytochrome c was not affected at low digitonin con- 
centrations where holocytochrome e formation was reduced. 
Cytochrome c heme lyase, or some other component necessary 
for the covalent attachment of heme to apocytochrome c, 
appears to be localized in the mitochondrial intermembrane 
space and fractionates separately from the apocytochrome 
binding activity. 
DISCUSSION 
Previous methods for determining the covalent attachment 
of heme to apocytochrome c by the activity of cytochrome c 
heme lyase have been based on secondary changes in the 
protein molecule as a consequence of heme linkage. In our 
laboratory, we have made use of differential antibodies raised 
against apo- and holocytochrome c which do not cross-react 
under defined conditions [12, 18-22, 301. In yeast, cyto- 
chrome c heme lyase activity has been examined by making 
use of the differential sensitivity of apo- and holocytochrome 
c to proteolytic digestion by trypsin under reducing conditions 
[23 - 261. In the current study we have established a method 
for directly measuring the covalent linkage of heme to 
apocytochrome c which is totally independent of subsequent 
conformational changes in protein structure which may not 
occur under certain circumstances. 
Formation of holocytochrome c was dependent on ex- 
ogenously added hemin and, as observed previously [20], 
could be inhibited by the analogue deuterohemin. Deutero- 
hemin apparently has similar affinity for cytochrome c heme 
lyase as the competent substrate hemin since 50% inhibition 
of activity occurred when the concentrations of both were 
equal. Blockage of holocytochrome c formation by 
deuterohemin could be reversed by protohemin. Very high 
concentrations of deuterohemin, however, abolished holocy- 
tochrome c formation irreversibly. It is possible that accumu- 
lation of high concentrations of heme compounds has per- 
turbating effects on mitochondrial membranes and upsets 
other essential parts of the import pathway, such as receptor 
binding or presentation of the apocytochrome c cysteines to 
cytochrome c heme lyase. Indeed, reduction in the ability of 
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Fig. 6. Submitochondrial localization qf cytochrome c heme lyase by 
digitonin fractionation. Mitochondria were fractionated with in- 
creasing concentrations of digitonin as described in Materials and 
Methods. Proteins were quantified by enzymatic or immunological 
methods: (0 )  Activity or content in pellets; (0) activity or content 
in supernatants. (A) Cytochrome c heme lyase activity; (B) number 
of high-affinity binding sites for apocytochrome c ;  (C) adenylate 
kinase activity (intermembrane space marker); (D) 20-kDa protein 
content; (E) holocytochrome c content (intermembrane space 
marker); (F) porin content (outer membrane marker); (G) fumarase 
activity (matrix marker); (H) ADP/ATP carrier content (inner mem- 
brane marker) 
mitochondria to bind apocytochrome c was observed in the 
presence of high concentrations of deuterohemin, although 
displacement of pre-bound apocytochrome c did not occur 
(unpublished experiments). 
Holocytochrome c formation could also be inhibited with 
N-ethylmaleimide which specifically and irreversibly reacts 
with free sulphydryl groups [44]. The data presented here 
indicate that the cysteine sulphydryl groups of the apocyto- 
chrome c in the reticulocyte lysate were reduced and therefore 
able to react with N-ethylmaleimide (NEM). This reaction 
appears to be the cause for NEM inhibtion of holocytochrome 
c formation, and not an inactivation of a component of the 
import machinery. Furthermore, since the conversion of 
apocytochrome c (which had been pre-bound to mitochondria 
before NEM treatment) to holocytochrome c was blocked by 
NEM, then the cysteines of bound apocytochrome c were also 
in the reduced state. Altogether, these data indicate that in 
the system used here the suphydryl groups of the cysteines of 
apocytochrome c remain reduced up to the stage where they 
are presented to cytochrome c heme lyase for covalent attach- 
ment of heme. 
Besides heme and apocytochrome c, holocytochrome c 
formation by mitochondria requires NADH and an unknown 
factor that is present in cytosolic fractions and reticulocyte 
lysate. The exact role of these cofactors is unclear. In the first 
case, it has been well established that import of cytochrome 
c does not require a potential across the inner mitochondrial 
membrane [21]. This was further substantiated here by experi- 
ments in which the membrane potential was dissipated 
(valinomycin/K+) or its generation was blocked (antimycin 
A/oligomycin) and NADH-dependent holocytochrome c 
formation was unaffected. Similarly, when a membrane poten- 
tial was generated in the absence of NADH (tetramethyl- 
phenylenediamine/ascorbate), only negligible holocyto- 
chrome c formation occurred. NADH was not required for 
the binding of apocytochrome c to mitochondria and the 
effects of N-ethylmaleimide suggest that the cysteine residues 
involved in heme attachment exist in their reduced state 
throughout import so that NADH is not required for their 
reduction prior to holocytochrome c formation. There is the 
possibility that NADH is required for reduction of the heme 
irons from Fe3+ to Fez+ before enzymatic linkage of heme 
to apocytochrome c can occur. The exact role of NADH in 
the import of cytochrome c, however, remains unclear. 
A cofactor that is present in both reticulocyte lysate and 
in Neurospora cytosolic preparations was also required for 
holocytochrome c formation (Fig. 5). A similar stimulatory 
effect by cytosolic factors on holocytochrome c formation 
has been described in yeast. With yeast this factor could be 
substituted for by an NADPH-regenerating system [45]. In 
our experiments, a regenerating system for either NADPH 
(isocitrate plus isocitrate dehydrogenase) or for NADH 
(lactate plus lactate dehydrogenase, or glucose 6-phosphate 
plus glucose-6-phosphate dehydrogenase) did not substitute 
for the requirement of the cytosolic cofactor. The factor 
appears to be a temperature-stable, non-protein component 
of Neurospora cytosol. It was readily dialyzable and may 
therefore be able to pass through the outer mitochondrial 
membrane to the intermembrane space via the channels 
formed by porin. The role of this cofactor in cytochrome c 
import is unclear. It is not involved in the binding of 
apocytochrome c to mitochondria and is presumably required 
for either the activity of cytochrome c heme lyase or for some 
events within the outer membrane which are required for 
presentation of apocytochrome c to the heme attaching 
enzyme. 
The apparent location of cytochrome c heme lyase in the 
mitochondrial intermembrane space, as determined here, has 
been incorporated into our previous hypothesis on the 
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Fig. 7. Puthwu~  of gmchrorne c import into mitochondria. (1) Nuclear-coded apocytochrome c is synthesized on cytoplasmic ribosomes and 
released into a cytosolic pool. (2) The apocytochrome c protein interacts with cellular membranes, including the mitochondrial outer membrane, 
with low affinity and in a reversible manner, and spontaneously inserts into the lipid bilayer. (3) Apocytochrome c is bound with high affinity 
to a protein located at  the inner face of the outer mitochondrial membrane. (4) Heme is covalently attached to cysteines 18 and 21 by the 
enzyme cytochrome c heme lyase with (5) concomitant translocation across the outer membrane by the resulting con formational change. (6) 
Holocytochromc c migrates to its functional location in association with cytochrome c reductase and cytochrome c oxidase at the outer face 
of the inner membrane. Abbreviations: BP, apocytochrome c binding protein; H, heme; HL, cytochrome c heme lyase 
assembly of cytochrome c (Fig. 7). Nuclear-coded apocyto- 
chrome c is synthesized on free ribosomes in the cytosol and 
is released into a cytosolic pool. Other than the N-terminal 
methionine which is removed as a post-translational modifica- 
tion, the apoprotein does not contain a cleavable N-terminal 
targeting prepiece. The positively charged apocytochrome c 
is able to interact with anionic phospholipid head groups and 
can spontaneously insert, with low affinity, part way through 
the lipid bilayer of cell membranes [46 - 501. In mitochondria, 
apocytochrome c is bound with high affinity by a binding 
protein from the intermembrane space. This complex is 
arranged in the outer membrane to facilitate the next step of 
transfer. At this stage, the bound apocytochrome c can still 
be displaced from mitochondria with an excess of externally 
added apocytochrome c [22]. Heme is then covalently attached 
to cysteines 18 and 21 of apocytochrome c,  which are presum- 
ably exposed to the intermembrane space, by the enzyme 
cytochrome c heme lyase. The resulting conformational 
change pulls the protein completely through the lipid bilayer 
of the outer membrane and it is released into the intermem- 
brane space as holocytochrome c where it subsequently 
migrates to its functional location in association with cyto- 
chrome c reductase and cytochrome c oxidase at the outer 
face of the inner membrane. It should be mentioned that, in 
yeast, cytochrome c heme lyase was reported to be membrane- 
bound [23], although the exact topological location was not 
determined. 
Import into and maturation of cytochrome c in mitochon- 
dria appears to require at least two protein components, 
namely the apocytochrome c binding protein and cytochrome 
c heme lyase. In yeast, two similar functions have been 
identified by genetic analysis [51]. Mutations at two loci, 
unlinked to cytochrome c structural genes, appear to code for 
a heme attaching activity (CYC 3) and a protein which may 
facilitate apocytochrome c transport across the outer mem- 
brane (CYC 2). 
In summary, cytochrome c heme lyase plays a central 
role in the transfer of apocytochrome c into mitochondria. It 
appears that the functional assembly of cytochrome c, namely 
covalent attachment of heme, is conveniently linked to the 
translocation of the protein across the outer mitochondrial 
membrane during import. 
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